rdf:type |
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0014822,
umls-concept:C0030705,
umls-concept:C0086418,
umls-concept:C0220825,
umls-concept:C0376152,
umls-concept:C0871261,
umls-concept:C1516960,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
1993-3-25
|
pubmed:abstractText |
Anaemia is a frequent finding in patients with cancer and may be due to different causes, including blunted erythropoietin production.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0390-6078
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
494-501
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1289186-Aged,
pubmed-meshheading:1289186-Aged, 80 and over,
pubmed-meshheading:1289186-Anemia,
pubmed-meshheading:1289186-Cost-Benefit Analysis,
pubmed-meshheading:1289186-Erythroid Precursor Cells,
pubmed-meshheading:1289186-Erythropoiesis,
pubmed-meshheading:1289186-Erythropoietin,
pubmed-meshheading:1289186-Female,
pubmed-meshheading:1289186-Humans,
pubmed-meshheading:1289186-Immunologic Factors,
pubmed-meshheading:1289186-Iron,
pubmed-meshheading:1289186-Male,
pubmed-meshheading:1289186-Middle Aged,
pubmed-meshheading:1289186-Neoplasms,
pubmed-meshheading:1289186-Pilot Projects,
pubmed-meshheading:1289186-Recombinant Proteins,
pubmed-meshheading:1289186-Stimulation, Chemical
|
pubmed:articleTitle |
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
|
pubmed:affiliation |
Dipartimento di Medicina Interna e Terapia Medica, IRCCS Policlinico San Matteo, Pavia, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|